Cross-domain feature disentanglement for interpretable modeling of tumor microenvironment impact on drug response

• URL: http://arxiv.org/abs/2311.09264v1
• Date: Wed, 15 Nov 2023 07:50:54 GMT
• Title: Cross-domain feature disentanglement for interpretable modeling of tumor microenvironment impact on drug response
• Authors: Jia Zhai and Hui Liu
• Abstract summary: We propose a domain adaptation network for disentanglement to separate representations of cancer cells and TME of a tumor in patients. To ensure generalizability to novel drugs, we applied a graph attention network to learn the latent representation of drugs, allowing us to linearly model the drug perturbation on cellular state in latent space.
• Score: 4.930226504666259
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: High-throughput screening technology has facilitated the generation of large-scale drug responses across hundreds of cancer cell lines. However, there exists significant discrepancy between in vitro cell lines and actual tumors in vivo in terms of their response to drug treatments, because of tumors comprise of complex cellular compositions and histopathology structure, known as tumor microenvironment (TME), which greatly influences the drug cytotoxicity against tumor cells. To date, no study has focused on modeling the impact of the TME on clinical drug response. This paper proposed a domain adaptation network for feature disentanglement to separate representations of cancer cells and TME of a tumor in patients. Two denoising autoencoders were separately used to extract features from cell lines (source domain) and tumors (target domain) for partial domain alignment and feature decoupling. The specific encoder was enforced to extract information only about TME. Moreover, to ensure generalizability to novel drugs, we applied a graph attention network to learn the latent representation of drugs, allowing us to linearly model the drug perturbation on cellular state in latent space. We calibrated our model on a benchmark dataset and demonstrated its superior performance in predicting clinical drug response and dissecting the influence of the TME on drug efficacy.

Related papers

• Variational and Explanatory Neural Networks for Encoding Cancer Profiles and Predicting Drug Responses [40.80133767939435]
  Existing AI models face challenges due to noise in transcriptomics data and lack of biological interpretability. We introduce VETE, a novel neural network framework that incorporates a variational component to mitigate noise effects. VETE bridges the gap between AI-driven predictions and biologically meaningful insights in cancer research.
  arXiv  Detail & Related papers  (2024-07-05T13:13:02Z)
• Mask-Enhanced Segment Anything Model for Tumor Lesion Semantic Segmentation [48.107348956719775]
  We introduce Mask-Enhanced SAM (M-SAM), an innovative architecture tailored for 3D tumor lesion segmentation. We propose a novel Mask-Enhanced Adapter (MEA) within M-SAM that enriches the semantic information of medical images with positional data from coarse segmentation masks. Our M-SAM achieves high segmentation accuracy and also exhibits robust generalization.
  arXiv  Detail & Related papers  (2024-03-09T13:37:02Z)
• Cross-modality Guidance-aided Multi-modal Learning with Dual Attention for MRI Brain Tumor Grading [47.50733518140625]
  Brain tumor represents one of the most fatal cancers around the world, and is very common in children and the elderly. We propose a novel cross-modality guidance-aided multi-modal learning with dual attention for addressing the task of MRI brain tumor grading.
  arXiv  Detail & Related papers  (2024-01-17T07:54:49Z)
• LLM-driven Multimodal Target Volume Contouring in Radiation Oncology [46.23891509553877]
  Large language models (LLMs) can facilitate the integration of the textural information and images. We present a novel LLM-driven multimodal AI, namely LLMSeg, that is applicable to the challenging task of target volume contouring for radiation therapy. We demonstrate that the proposed model exhibits markedly improved performance compared to conventional unimodal AI models.
  arXiv  Detail & Related papers  (2023-11-03T13:38:42Z)
• Generating counterfactual explanations of tumor spatial proteomes to discover effective strategies for enhancing immune infiltration [44.99833362998488]
  The tumor microenvironment (TME) significantly impacts cancer prognosis due to its immune composition. Here, we formulate T-cell infiltration prediction as a self-supervised machine learning problem. We apply our framework to melanoma, colorectal cancer liver metastases, and breast tumor data, discovering perturbations predicted to support T-cell infiltration.
  arXiv  Detail & Related papers  (2022-11-08T05:46:02Z)
• TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response [12.86640026993276]
  We proposeTransformer based network for Cancer drug Response (TCR) to predict anti-cancer drug response. By utilizing an attention mechanism, TCR is able to learn the interactions between drug atom/sub-structure and molecular signatures efficiently. Our study highlights the prediction power of TCR and its potential value for cancer drug repurpose and precision oncology treatment.
  arXiv  Detail & Related papers  (2022-07-10T13:01:54Z)
• Imaging-based histological features are predictive of MET alterations in Non-Small Cell Lung Cancer [1.2885809002769635]
  MET is a proto-oncogene whose activation in non-small cell lung cancer leads to increased cell growth and tumor progression. We investigated the association of cell-morphological features with MET amplifications and MET exon 14 deletions. A predictive model could distinguish MET wild-type from MET amplification or MET exon 14 deletion.
  arXiv  Detail & Related papers  (2022-03-18T17:11:05Z)
• Novel Local Radiomic Bayesian Classifiers for Non-Invasive Prediction of MGMT Methylation Status in Glioblastoma [0.0]
  Expression of the O6-methylguanine-DNA-methyltransferase (MGMT) gene in glioblastoma tumor tissue is of clinical importance. Currently, MGMT methylation is determined through an invasive brain biopsy and subsequent genetic analysis of the extracted tumor tissue. We present novel Bayesian classifiers that make probabilistic predictions of MGMT methylation status based on radiomic features extracted from FLAIR-sequence magnetic resonance imagery (MRIs)
  arXiv  Detail & Related papers  (2021-11-30T04:53:23Z)
• Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to characterize Tumor Field Effect: Application to Survival Prediction in Glioblastoma [2.1916334019121537]
  The concept of tumor field effect implies that cancer is a systemic disease with its impact way beyond the visible tumor confines. We present an integrated MRI-based descriptor, radiomic-Deformation and Textural Heterogeneity (r-DepTH) This descriptor comprises measurements of the subtle perturbations in tissue deformations throughout the surrounding normal parenchyma due to mass effect.
  arXiv  Detail & Related papers  (2021-03-12T17:38:54Z)
• Stan: Small tumor-aware network for breast ultrasound image segmentation [68.8204255655161]
  We propose a novel deep learning architecture called Small Tumor-Aware Network (STAN) to improve the performance of segmenting tumors with different size. The proposed approach outperformed the state-of-the-art approaches in segmenting small breast tumors.
  arXiv  Detail & Related papers  (2020-02-03T22:25:01Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.